[Eeglablist] Translational Post-Doctoral T32 Training Program in Neurodevelopment at Boston Children’s Hospital
Faja, Susan
Susan.Faja at childrens.harvard.edu
Mon Apr 24 11:34:10 PDT 2023
The Translational Post-Doctoral T32 Training Program in Neurodevelopment at Boston Children’s Hospital is seeking applications (due April 29th) for a 2-year postdoctoral program. Please see the program description<https://urldefense.com/v3/__https://rsztnc.org/wp-content/uploads/2023/01/Neurodevelopmental-T32-Fellowship-Infosheet-Deadline-Extended.pdf__;!!Mih3wA!E_FhXDBfDAuYS3JZ85MWnuR1eaLd_rvIX7i5vkEI9mSnDuQrGetR21Fj3NwN7FGwvTpscQ8VWBuupdcaGOcYfzkHxNTOGA7p84ZiAA$ > for more details.
Interdisciplinary–Translational Post-Doctoral Training Program in Neurodevelopment at Boston Children’s Hospital/Harvard Medical School
Basic and Clinical Research
APPLICATION DEADLINE EXTENDED TO APRIL 29th!
Two-year fellowships funded by the National Institute of Mental Health (NIMH) are available for MD, PhD, MD/PhD applicants from the fields of psychiatry, psychology, pediatrics, neurology, genetics, neuroscience, developmental biology, computer science and related fields who seek to improve or expand their ability to conduct interdisciplinary-translational research in neurodevelopmental disorders.
Trainees accepted into the postdoctoral training program will work collaboratively with two program mentors (one preclinical and one clinical), who will help to define, enhance and monitor the trainee’s research program and career trajectory. The training program also offers various didactic courses and activities (e.g., workshops on research methods and grant writing, journal club and career lunches) to promote professional development.
This program has an outstanding success rate for training postdoctoral fellows who go on to become highly productive independent researchers. Creative, energetic, and dedicated candidates are particularly encouraged to apply, as are candidates from backgrounds typically underrepresented in higher education.
The application deadline has been extended to April 29th, with the expectation that trainees will be selected by May 16th and will start July 1st, 2022, at the earliest. Applicants must be U.S. citizens or permanent residents with an MD and/or PhD (must be completed at the time training begins). Commitment to the goals of the program and strong academic and research credentials are important criteria used in the selection process. For additional information on the T32 training program and application procedures, please contact the Program Administrator, Gregory Geisel at T32translationaldevelopment at childrens.harvard.edu.<mailto:T32translationaldevelopment at childrens.harvard.edu.>
Children’s Hospital/ Harvard Medical School is committed to affirmative action, equal opportunity and the diversity of its workforce. We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law.
Susan Faja, PhD
Associate Professor, Department of Pediatrics | Department of Psychiatry | Harvard Medical School
Research Associate | Laboratories of Cognitive Neuroscience | BCH 3178
Boston Children’s Hospital | Two Brookline Place | Brookline, MA 02445
617-919-4486 | susan.faja at childrens.harvard.edu | https://urldefense.com/v3/__https://www.childrenshospital.org/research/labs/faja-laboratory__;!!Mih3wA!E_FhXDBfDAuYS3JZ85MWnuR1eaLd_rvIX7i5vkEI9mSnDuQrGetR21Fj3NwN7FGwvTpscQ8VWBuupdcaGOcYfzkHxNTOGA6FzWNXwQ$
Pronouns: she / her / hers
The above email may contain patient identifiable or confidential information. Because email is not secure, please be aware of the risks associated with email transmission.
The information is intended for the individual named above. If you are not the intended recipient, any disclosure, copying, distribution or use of the contents of this information is prohibited. Please notify the sender by reply email, and then destroy all copies of the message and any attachments.
More information about the eeglablist
mailing list